Conference Service Mandl

abstract: BIT Life Sciences' WSA-2008 is a focused event for updating the current advances in worldwide R & D of Novel Antiviral Therapeutics. The anticipated attendees will represent top-level decision makers from leading biotech, pharmaceutical, and healthcare organizations. WSA-2008 is preparing to meet the demand on expert views, up-to-the-minute industry intelligence, and professional presentation, and poster sessions. WSA -2008 conference also provides an ideal forum for the promotion of relevant companies, products, technologies and services.

abstract: IDDST 2008 will offer an Olympian gathering to emphasize the pioneer explorations of basic research and technology development across therapeutic areas, to update current status all phase drug discovery and development timely. The program will also provide a profound coverage on global trend of R & D of innovative therapeutics in relation with major disease areas. Numerous Sessions cover pipeline transfer strategy and licensing, CRO and CMO in China. Through IDDST 2008, you will also gain deep insight into the strategies of major pharma players in integrating scientific, technological, talent and business resources in a flat world to increase business competitive capacities. You will also enjoy the Joint Symposium on Frontier of Medicinal Chemistry sponsored by ACS Medchem Division.

abstract: The BIT's 1st Annual World Congress of Vaccine provides highquality and current reports of scientific progress featured in calling for presentations and submitted abstracts presenting at Six Remarkable Tracks, which cover a broad spectrum of current status of Vaccine development in not only human vaccination fields, but also to extend to Livestock, Agricultural and Aquaculture Vaccine R & D and business development. The disparate fields covered in both human and veterinary vaccinology encourage valuable cross-fertilization of ideas and approaches among researchers otherwise focused on specific diseases or methods.